Header Logo

Connection

MARY PAUL to Diketopiperazines

Back to Details
This is a "connection" page, showing publications MARY PAUL has written about Diketopiperazines.
MARY PAUL
Connection Strength
0.469
Diketopiperazines
  1. Safety and pharmacokinetics of oral and long-acting injectable cabotegravir or long-acting injectable rilpivirine in virologically suppressed adolescents with HIV (IMPAACT 2017/MOCHA): a phase 1/2, multicentre, open-label, non-comparative, dose-finding study. Lancet HIV. 2024 Apr; 11(4):e211-e221.
    View in: PubMed
    Score: 0.469
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.